Expert.ai Unveils New AI Tools for Pharma and Life Sciences

Nov 6, 2025
Expert.ai announced new AI-powered solutions at BioTechX Europe 2025 to improve research, clinical trial design, and regulatory processes across the pharmaceutical and life sciences industries.

expert.ai announced in a press release the launch of new AI solutions for the pharmaceutical, healthcare, and life sciences sectors. The announcement was made at BioTechX Europe 2025 in Basel, where the company introduced tools designed to streamline research, clinical trial design, and regulatory documentation.

The new offerings include EIX-Submission Readiness for regulatory workflows, EIX-Preclinical Document Intelligence for managing preclinical documentation, EIX-Clinical Trials Intelligence for analyzing data from clinical registries and publications, and EIX-IP Detection for insights across patents and research data.

Each solution leverages the company’s hybrid AI approach, combining natural language understanding with machine learning to automate complex processes. The tools aim to reduce manual effort, increase accuracy, and support compliance throughout the research and development cycle.

These capabilities are available through the company’s EidenAI Suite, extending expert.ai’s focus on intelligent document automation and data analysis for the life sciences industry.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.